Dr
Sophie-Beth
Aylett

Experience

Sophie-Beth is a Chartered (UK) Patent Attorney and European Patent Attorney in the biotechnology and life sciences fields with particular specialist knowledge in immunotherapy, antibodies, cancer therapeutics, vaccines and diagnostics. She has extensive experience advising a range of clients including first-time inventors, start-ups and SME's to large established corporations and overseas associates.

Sophie-Beth acts before the UKIPO, EPO and WIPO. Her work includes drafting, filing and prosecuting patent applications, post-grant opposition and appeal proceedings before the EPO and matters relating to IP due diligence. Sophie-Beth focuses on providing commercially relevant, pragmatic advice to clients in line with their business objectives and is proactive in coordinating the strategic planning and management of clients' patent portfolios.

Sophie-Beth is a member of the HGF Venture team with Kerry Rees and provides IP due diligence service to life science investors. Consequently, Sophie-Beth also works with early stage companies to help them align their IP strategies with their business plan to maximise the return on investment.

Sophie-Beth graduated with a first class degree in Pharmacology from the University of Bath. As part of her degree, she spent a year working at a leading biopharmaceutical company, UCB. Sophie-Beth then went on to gain a PhD in Metabolic Biochemistry from University College London. Her research focused on the genetic and biochemical mechanisms responsible for the central folate deficiency associated with mitochondrial disorders.